Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,450Revenue $M2,154Net Margin (%)16.9Z-Score6.3
Enterprise Value $M8,596EPS $2.1Operating Margin %20.4F-Score8
P/E(ttm))21.6Cash Flow Per Share $0Pre-tax Margin (%)21.2Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %32.8Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %46.8Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %34.1ROA % (ttm)17.7Higher Current Ratio y-yY
Dividend Yield %0.6Insider Buy (3m)0ROE % (ttm)27.5Less Shares Outstanding y-yY
Payout Ratio %12.0Shares Outstanding M170ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
$ 49.6118%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
$ 49.6115%Add 56.3%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
$ 49.6136%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
$ 49.6145%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
$ 49.6165%New holding, 604555 sh.604,555
RDYBrian Rogers 2007-09-30 Sold Out -0.33%$15.25 - $16.85
$ 49.61208%Sold Out0
RDYBrian Rogers 2007-06-30 Buy 0.33%$15.25 - $17.25
$ 49.61204%New holding, 4250000 sh.4,250,000
RDYMohnish Pabrai 2006-09-30 Sold Out -1.11%$13.55 - $16.04
$ 49.61224%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RDY Ken Fisher 2014-06-303,773,1142.220.34+62.43%
Premium Most recent portfolio changes are included for Premium Members only!

RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

Quarterly/Annual Reports about RDY:

    News about RDY:

    Articles On GuruFocus.com
    Should You Buy Actavis? Mar 18 2014 
    Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
    5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
    Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
    Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

    More From Other Websites
    Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014 Oct 17 2014
    Emerging Markets Monday In Review Oct 13 2014
    Sucampo Enters into Settlement Agreement for Amitiza Oct 13 2014
    Generics Firms Step Up Their Game In Branded Drugs Oct 06 2014
    Today's Market Thorns, Roses, and All Time Highs... Plus an Extra... Sep 25 2014
    Dr. Reddy's (RDY) Generic Xopenex Launched in the US Sep 25 2014
    Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP Sep 24 2014
    Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP Sep 24 2014
    Should India Be On Investors' Radars? Sep 22 2014
    India Must Fix Its Drug Quality Problem Sep 17 2014
    India: Stock Picks As States Reform Aug 27 2014
    Tata Motors, Icici Bank Ride A Strong Week In India Aug 22 2014
    3 Stocks Dragging The Health Care Sector Downward Aug 11 2014
    Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y Aug 01 2014
    Impax Shares Plunge Post FDA Inspection of Taiwan Facility Jul 31 2014
    Dr. Reddy’s Q1 FY15 Financial Results Jul 30 2014
    Dr. Reddy’s Q1 FY15 Financial Results Jul 30 2014
    Who Benefits From India's New Budget Jul 28 2014
    Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher Jul 24 2014
    Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014 Jul 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial